THE EFFECT OF A SEROTONIN ANTAGONIST (UML 491) IN CARCINOID DISEASE
- 25 November 1961
- journal article
- Published by Elsevier in The Lancet
- Vol. 278 (7213) , 1172-1174
- https://doi.org/10.1016/s0140-6736(61)90846-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- FREE SEROTONIN IN HUMAN PLASMA: Quantitative and Qualitative EstimationThe Lancet, 1961
- CARCINOID SYNDROME: Serotonin Release Induced with Intravenous Adrenaline or NoradrenalineThe Lancet, 1961
- FACIAL FLUSHING PRODUCED IN PATIENTS WITH CARCINOID SYNDROME BY INTRAVENOUS ADRENALINE AND NORADRENALINEThe Lancet, 1959
- SerotoninNew England Journal of Medicine, 1959
- SEROTONIN METABOLISM IN CARCINOID SYNDROME WITH METASTATIC BRONCHIAL ADENOMAJAMA, 1959
- Serotonin (5-Hydroxytryptamine); the Last Four YearsPhysiological Reviews, 1958
- The effect of intraluminal application of 5‐hydroxytryptamine and 5‐hydroxytryptophan on peristalsis; the local production of 5‐HT and its release in relation to intraluminal pressure and propulsive activityThe Journal of Physiology, 1958
- Comparison of Lysergic Acid Derivatives and Antihistamines as Inhibitors of the Edema Provoked in the Rat’s Paw by SerotoninInternational Archives of Allergy and Immunology, 1958